Amy Bachrodt serves as Executive at Maze Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Amy Bachrodt has executed 7 insider transactions totaling $606.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 30, 2025 involved exercising options for 2,605 shares valued at $27.1K.
Amy Bachrodt currently holds 17,965 shares of Maze Therapeutics, Inc. (MAZE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amy Bachrodt has been a net seller of MAZE stock. They have purchased $0 and sold $606.2K worth of shares.
Amy Bachrodt's most recent insider trade was on Dec 30, 2025, when they sold 2,605 shares at $10.42 per share.
Get notified when new Form 4 filings are submitted
| $40.08 |
| Discretionary |
| Dec 30, 2025 | MAZE | $25.0K | Option Exercise | 2,395 | $10.42 | Discretionary |
| Dec 29, 2025 | MAZE | $1.3K | Option Exercise | 124 | $10.42 | Discretionary |
| Dec 29, 2025 | MAZE | $102.9K | Option Exercise | 9,876 | $10.42 | Discretionary |
| Dec 29, 2025 | MAZE | $381.1K | Sale | 9,400 | $40.54 | Discretionary |
| Dec 29, 2025 | MAZE | $24.7K | Sale | 600 | $41.16 | Discretionary |